Publication | Closed Access

Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: Results of the MEDCOR trial

Medcor TrialPercutaneous Coronary InterventionLong-term EffectCardiovascular DiseaseMedicineEndothelial DysfunctionCardiovascular PharmacologyCardiologyVascular BiologyPharmacotherapyPharmacologyAtherosclerosisCoronary Artery DiseaseMyocardial Infarction